Skip to content
Psychopharmacology Bulletin › All Volumes & Issues › VOL 52 No. 3 › Correlation of 1846G>A...
DRUG DISPOSITION & PHARMACOKINETICS

Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses

AA Parkhomenko, MS Zastrozhin, VYu Skryabin, VA Ivanchenko, SA Pozdniakov, VV Noskov, IA Zaytsev, NP Denisenko, KA Akmalova, EA Bryun, DA Sychev
Psychopharmacology Bulletin 52(3): 58-67, 2022/06/27; https://doi.org/10.64719/pb.4444
Find this article on: PubMed PMC — free full text

Abstract

Previous studies have shown that haloperidol biotransformation occurs with participation of the CYP2D6 isoenzyme. The CYP2D6 gene is highly polymorphic, which may contribute to differences in its activity and in the haloperidol biotransformation rates across different individuals, resulting in variable drug efficacy and safety profiles.

Keywords

alcoholic hallucinosisCYP2D6haloperidolpersonalized medicinepharmacogenetics

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In
Not yet subscribed? View subscription options

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

AA Parkhomenko, MS Zastrozhin, VYu Skryabin, VA Ivanchenko, SA Pozdniakov, VV Noskov, IA Zaytsev, NP Denisenko, KA Akmalova, EA Bryun, DA Sychev. Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses. Psychopharmacology Bulletin. 2022/06/27; 52(3):58-67. https://doi.org/10.64719/pb.4444